Prelude Capital Management’s Vascular Solutions Inc VASC Stock Holding History

Prelude Capital Management’s Portfolio VASC Stock Details VASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-190	Closed	-$7K	–	1731
2015 Q4	$7K	Sell	190 -4,610	-96%	-$156K	﹤0.01%	1298
2015 Q3	$156K	Sell	4,800 -600	-11%	-$21.5K	0.02%	695
2015 Q2	$187K	Buy	5,400 +1,800	+50%	+$58.7K	0.03%	634
2015 Q1	$109K	Buy	3,600 +2,100	+140%	+$60.3K	0.02%	974
2014 Q4	$41K	Buy	+1,500	New	+$40.7K	0.01%	1355
2014 Q2	–	Sell	-1,400	Closed	-$37K	–	2337
2014 Q1	$37K	Buy	+1,400	New	+$34.8K	0.01%	1437

Other funds holding VASC

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prelude Capital Management's VASC Position: Q1 2016 in Review

Prelude Capital Management sold out of Vascular Solutions Inc (VASC) in Q1 2016, closing a stake of 190 shares — an estimated $7K sold.

Prelude Capital Management first reported a position in VASC in Q1 2014 and held it in 6 quarters. The position peaked at $187K in Q2 2015. 135 funds tracked by Wall St. Rank hold VASC as of Q1 2016.

Prelude Capital Management reported no remaining Vascular Solutions Inc position as of Q1 2016 after selling out during the quarter.
Prelude Capital Management sold 190 Vascular Solutions Inc shares in Q1 2016, an estimated $7K.
Prelude Capital Management first reported a position in Vascular Solutions Inc in Q1 2014 and held it in 6 quarters.
Prelude Capital Management's Vascular Solutions Inc position peaked at $187K in Q2 2015.
135 funds tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2016.

Based on Prelude Capital Management's 13F filing for Q1 2016, filed 16 May 2016.